Cambrian BioPharma Inc, 10% Owner at Sensei Biotherapeutics, Inc. (SNSE), bought 2,500 shares at $3.60 ($9K) on 2022-02-28, disclosed to the SEC on 2022-03-01.
Open-market purchase of $9k SNSE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.60 | 42 | $151 | 1.7% |
| 2 | $3.60 | 2,458 | $9K | 98.3% |
| Total | $3.60 avg | 2,500 | $9K | 100% |
| Filing → |
| SNSE | SELL | 2025-12-08 | $398K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $136K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $15K | — | Filing → |